Ventyx Biosciences
VTYX
VTYX was delisted on the 3rd of March, 2026.
116 hedge funds and large institutions have $51.1M invested in Ventyx Biosciences in 2025 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 39 increasing their positions, 34 reducing their positions, and 23 closing their positions.
15% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 34
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less funds holding
Funds holding: 124 → 116 (-8)
14.59% less ownership
Funds ownership: 77% → 62.42% (-15%)
35% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 23
36% less call options, than puts
Call options by funds: $39K | Put options by funds: $61K
57% less capital invested
Capital invested by funds: $119M → $51.1M (-$68.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$4.21M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
+$2.48M |
| 3 |
MAM
Monaco Asset Management
Monaco
|
+$1.54M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$1.36M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$753K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$5.96M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$5.59M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$5.3M |
| 4 |
Morgan Stanley
New York
|
-$2.81M |
| 5 |
SCM
Sio Capital Management
New York
|
-$2.51M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
126
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$47.7K | -21,781 | Closed |
|
127
Tudor Investment Corp
Stamford,
Connecticut
| – | -$38.9K | -17,780 | Closed |
|
|
PCM
128
Prelude Capital Management
New York
| – | -$38.3K | -17,499 | Closed |
|
|
AC
129
AXQ Capital
Jersey City,
New Jersey
| – | -$28.8K | -13,154 | Closed |
|
|
CCG
130
Catalina Capital Group
Torrance,
California
| – | -$25.1K | -11,456 | Closed |
|
|
PD
131
Point72 (DIFC)
Dubai,
United Arab Emirates
| – | -$24.4K | -11,157 | Closed |
|
|
CA
132
CoreCap Advisors
Southfield,
Michigan
| – | -$1.23K | -561 | Closed |
|
133
Osaic Holdings
Scottsdale,
Arizona
| – | -$1.14K | -519 | Closed |
|
|
MPWT
134
MassMutual Private Wealth & Trust
Windsor,
Connecticut
| – | -$848 | -387 | Closed |
|
|
CA
135
Continuum Advisory
Eagle,
Idaho
| – | -$438 | -200 | Closed |
|
|
MA
136
Modus Advisors
Excelsior,
Minnesota
| – | -$329 | -150 | Closed |
|
|
FDCDDQ
137
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| – | -$263 | -120 | Closed |
|
VTYX Hedge Fund Activity: Q1 2025 in Review
116 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Ventyx Biosciences (VTYX) for Q1 2025, worth a combined $51.1M — down 57% from $119M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of VTYX and 15 opened new positions — a net loss of 8 holders — while 34 trimmed existing stakes and 39 added.
The largest buyer was Point72 Asset Management, adding an estimated $4.21M. The largest seller was UBS Group, cutting an estimated $5.96M.
- 116 institutional investors held Ventyx Biosciences (VTYX) as of Q1 2025, down from 124 in Q4 2024.
- Funds reported $51.1M of Ventyx Biosciences stock for Q1 2025, down 57% quarter-over-quarter.
- 15 funds opened new Ventyx Biosciences positions in Q1 2025 and 23 closed out, a net change of -8 holders.
- The largest Ventyx Biosciences buyer in Q1 2025 was Point72 Asset Management, an estimated $4.21M added.
- The largest Ventyx Biosciences seller in Q1 2025 was UBS Group, an estimated $5.96M sold.
Based on aggregated 13F filings for Q1 2025.